Hexamethylguanidinium | 44872-05-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Hexamethylguanidinium
• 英文别名: bis(dimethylamino)methylidene-dimethylazanium
• CAS: 44872-05-1
• 化学式: C₇H₁₈N₃
• 分子量: 144.24
• InChiKey: FCPMOQKUPRKDAN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  9.5
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• [DE] VERFAHREN ZUR HERSTELLUNG VON GUANIDINIUM-SALZEN<br/>[EN] METHOD FOR PRODUCING GUANIDINIUM SALTS<br/>[FR] PROCEDE DE PRODUCTION DE SELS DE GUANIDINIUM
  申请人：MERCK PATENT GMBH

  公开号：WO2005075413A1

  公开（公告）日：2005-08-18

  Die vorliegende Erfindung betrifft ein zweistufiges Verfahren zur Herstellung von Guanidinium-Salzen der Formel (1), wobei die Substituenten R eine in Anspruch 1 angegebene Bedeutung haben und A- ein Sulfonat, Alkyl- oder Aryl-Sulfat, Hydrogensulfat, Imid, Methanid, Carboxylat, Phosphat, Phosphinat, Phosphonat, Borat, Thiocyanat, Perchlorat, Fluorsilikat oder Nitrat ist, sowie Zwischenverbindungen aus diesem Verfahren.

  This invention relates to a two-step process for the production of guanidinium salts of formula (1), wherein the substituents R have the meaning as defined in claim 1 and A- is a sulfonate, alkyl or aryl sulfate, hydrogen sulfate, imide, methanide, carboxylate, phosphate, phosphinate, phosphonate, borate, thiocyanate, perchlorate, fluorosilicate, or nitrate, as well as intermediates from this process.
• Process for the preparation of guanidinium salts
  申请人：Ignatyev Nikolai (Mykola)

  公开号：US20070135645A1

  公开（公告）日：2007-06-14

  The present invention relates to a two-step process for the preparation of guanidinium salts of the formula (1), where the substituents R have a meaning indicated in claim, and A − is a sulfonate, alkyl- or arylsulfate, hydrogensulfate, imide, methanide, carboxylate, phosphate, phosphinate, phosphonate, borate, thiocyanate, perchlorate, fluorosilicate or nitrate, and to intermediate compounds from this process.

  本发明涉及一种用于制备式（1）的胍盐的两步法，其中取代基R的含义如权利要求中所示，A-是磺酸盐、烷基或芳基硫酸盐、氢硫酸盐、亚胺、甲基、羧酸盐、磷酸盐、亚磷酸盐、膦酸盐、硼酸盐、硫氰酸盐、高氯酸盐、氟硅酸盐或硝酸盐，并且涉及该过程的中间化合物。
• [DE] VERFAHREN ZUR HERSTELLUNG HETEROCYCLISCHER QUARTÄRER AMMONIUM- UND/ODER GUANIDINIUM-VERBINDUNGEN<br/>[EN] METHOD FOR PRODUCING HETEROCYCLIC QUATERNARY AMMONIUM AND/OR GUANIDINIUM COMPOUNDS<br/>[FR] PROCEDE POUR PRODUIRE DES COMPOSES AMMONIUM ET/OU GUANIDINIUM QUATERNAIRES HETEROCYCLIQUES
  申请人：BASF AG

  公开号：WO2006027069A1

  公开（公告）日：2006-03-16

  Verfahren zur Herstellung eines, ein heterocyclisches quartäres Ammonium- und/oder Guanidinium-Kation enthaltenden Zwischenprodukts für die Synthese heterocyclischer quartärer Ammonium- und/oder Guanidinium-Verbindungen, bei dem man heterocyclische quartäre Ammonium- und/oder Guanidinium-carboxylate mit einem oxidierenden Agens in Gegenwart eines Metalls aus der 8. bis 10. Gruppe des Periodensystems bei einer Temperatur von 0 bis 250°C und einem Druck von 0,05 bis 20 MPa abs oxidiert.

  制备含有杂环季铵和/或胍铵阳离子的中间体以合成杂环季铵和/或胍铵化合物的方法，其中将杂环季铵和/或胍铵羧酸盐与氧化剂在8至10族元素金属存在下，在0至250°C温度和0.05至20 MPa压力下氧化。
• METHOD FOR PRODUCING GLUCOSE BY ENZYMATIC HYDROLYSIS OF CELLULOSE THAT IS OBTAINED FROM MATERIAL CONTAINING LIGNO-CELLULOSE USING AN IONIC LIQUID THAT COMPRISES A POLYATOMIC ANION
  申请人：Balensiefer Tim

  公开号：US20100081798A1

  公开（公告）日：2010-04-01

  The present invention relates to a process for preparing glucose from a lignocellulose-comprising starting material, in which this is firstly treated with an ionic liquid and subsequently subjected to an enzymatic hydrolysis. The invention further relates to a process for preparing microbial metabolites, especially ethanol, in which the glucose obtained is additionally subjected to a fermentation.

  本发明涉及一种从含木质纤维素的起始物质制备葡萄糖的过程，首先将其与离子液体处理，然后经酶解处理。该发明还涉及一种制备微生物代谢产物，特别是乙醇的过程，其中所获得的葡萄糖额外经过发酵处理。
• HYDROXYLATED CONTRAST ENHANCEMENT AGENTS AND IMAGING METHOD
  申请人：Grimmond Brian James

  公开号：US20110243858A1

  公开（公告）日：2011-10-06

  A method of diagnostic imaging is disclosed comprising administering a medical formulation to a subject, the formulation comprising a contrast enhancement agent having structure I and salts thereof wherein R 1 is independently at each occurrence a hydroxy group, a C 1 -C 3 hydroxyalkyl group, or a C 1 -C 3 alkyl group, and b is 0-4; R 2 -R 7 are independently at each occurrence hydrogen, a C 1 -C 3 hydroxyalkyl group, or a C 1 -C 3 alkyl group, with the proviso that at least one of R 1 -R 7 is a hydroxy group or a C 1 -C 3 hydroxyalkyl group; and wherein Q is one or more charge balancing counterions; and one or more pharmaceutically acceptable carriers and excipients. The subject is subjected to a diagnostic imaging technique such as magnetic resonance imaging. The technique may be used in a variety of diagnostic imaging regimes, such as imaging of circulatory systems, genitourinary systems, hepatobiliary systems, central nervous systems, tumors, and abscesses among others.

  揭示了一种诊断成像方法，包括向受试者注射医用配方，该配方包括具有结构I和其盐的对比增强剂，其中R1在每次出现时独立地是羟基、C1-C3羟基烷基或C1-C3烷基，b为0-4；R2-R7在每次出现时独立地是氢、C1-C3羟基烷基或C1-C3烷基，但至少其中之一是羟基或C1-C3羟基烷基；Q是一个或多个电荷平衡的对离子；以及一个或多个药用载体和赋形剂。受试者接受诊断成像技术，如磁共振成像。该技术可用于各种诊断成像方案，如循环系统、泌尿系统、肝胆系统、中枢神经系统、肿瘤和脓肿等的成像。